Merck’s LAG-3 plus Keytruda combo fails Phase 3 in colorectal cancer

Merck’s efforts to combine its PD-1 blockbuster Keytruda with an experimental LAG-3 inhibitor hit a stumbling block Wednesday morning.

The company said a Phase 3 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

UnitedHealth exec Brian Thompson is killed in ‘brazen, targeted’ shooting

Brian Thompson, the CEO of UnitedHealth Group’s insurance division, was shot and killed in a targeted attack in New York City on Wednesday, ahead of

December 4, 2024

Expert Guide to Compound Medication Pharmacies and Companies

Compound medication pharmacies and companies: Introduction In the intricate landscape of global healthcare, compound medication stands as a bespoke solution to patient-specific needs. As the

May 31, 2024

Berlin-Based Lab Instruments Company Knauer Tackles Sustainability

At the same time as the UN Sustainability Summit in New York, laboratory measuring instrument manufacturer KNAUER launched this year’s Sustainability Week on September 18,

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.